CorMedix Inc CRMD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 03/27/24 EDT
4.16quote price arrow up+0.05 (+1.22%)
Volume
368,534
52 week range
2.57 - 6.09
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.16
  • 52 Week High6.09
  • 52 Week High Date06/22/23
  • 52 Week Low2.57
  • 52 Week Low Date11/15/23

Key Stats

  • Market Cap228.721M
  • Shares Out54.98M
  • 10 Day Average Volume0.57M
  • Dividend-
  • Dividend Yield-
  • Beta1.86
  • YTD % Change10.64

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.16
  • 52 Week High6.09
  • 52 Week High Date06/22/23
  • 52 Week Low2.57
  • 52 Week Low Date11/15/23
  • Market Cap228.721M
  • Shares Out54.98M
  • 10 Day Average Volume0.57M
  • Dividend-
  • Dividend Yield-
  • Beta1.86
  • YTD % Change10.64

RATIOS/PROFITABILITY

  • EPS (TTM)-0.92
  • P/E (TTM)-4.53
  • Fwd P/E (NTM)-4.55
  • EBITDA (TTM)-48.887M
  • ROE (TTM)-74.02%
  • Revenue (TTM)-
  • Gross Margin (TTM)98.62%
  • Net Margin (TTM)-133,987.00%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CorMedix Inc

 

Profile

MORE
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a...
Myron Kaplan J.D.
Independent Chairman of the Board
Joseph Todisco
Chief Executive Officer, Director
Matthew David M.D.
Chief Financial Officer, Executive Vice President
Erin Mistry
Executive Vice President, Chief Commercial Officer
Phoebe Mounts Ph.D.
Executive Vice President
Address
300 Connell Drive, Suite 4200
Berkeley Heights, NJ
07922
United States

Top Peers

SYMBOLLASTCHG%CHG
OMER
Omeros Corp
3.42-0.04-1.16%
SCPH
scPharmaceuticals Inc
5.03+0.12+2.44%
RLMD
Relmada Therapeutics Inc
4.59-0.10-2.13%
MDWD
Mediwound Ltd
15.10-0.46-2.96%
CYTH
Cyclo Therapeutics Inc
1.40UNCHUNCH